DK1905452T3 - Middel til forebyggelse eller behandling af glaukom - Google Patents

Middel til forebyggelse eller behandling af glaukom

Info

Publication number
DK1905452T3
DK1905452T3 DK06780961.6T DK06780961T DK1905452T3 DK 1905452 T3 DK1905452 T3 DK 1905452T3 DK 06780961 T DK06780961 T DK 06780961T DK 1905452 T3 DK1905452 T3 DK 1905452T3
Authority
DK
Denmark
Prior art keywords
preventing
treating glaucoma
glaucoma
treating
Prior art date
Application number
DK06780961.6T
Other languages
English (en)
Inventor
Ken Mizuno
Jiro Matsumoto
Original Assignee
Kowa Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kowa Co filed Critical Kowa Co
Application granted granted Critical
Publication of DK1905452T3 publication Critical patent/DK1905452T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Ophthalmology & Optometry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK06780961.6T 2005-07-12 2006-07-11 Middel til forebyggelse eller behandling af glaukom DK1905452T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2005203352 2005-07-12
PCT/JP2006/313740 WO2007007737A1 (ja) 2005-07-12 2006-07-11 緑内障を予防又は治療する薬剤

Publications (1)

Publication Number Publication Date
DK1905452T3 true DK1905452T3 (da) 2013-07-01

Family

ID=37637126

Family Applications (1)

Application Number Title Priority Date Filing Date
DK06780961.6T DK1905452T3 (da) 2005-07-12 2006-07-11 Middel til forebyggelse eller behandling af glaukom

Country Status (11)

Country Link
US (1) US8193193B2 (da)
EP (1) EP1905452B1 (da)
JP (1) JP4972552B2 (da)
KR (1) KR101333990B1 (da)
CN (1) CN101198355B (da)
DK (1) DK1905452T3 (da)
ES (1) ES2416334T3 (da)
HR (1) HRP20130876T1 (da)
PL (1) PL1905452T3 (da)
PT (1) PT1905452E (da)
WO (1) WO2007007737A1 (da)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0614974A2 (pt) 2005-08-30 2010-12-14 Asahi Kasei Pharma Corp composto, medicamento, inibidor da fosforilaÇço da cadeia leve regulatària da miosina, inibidor da via rho/rho quinase, e, mÉtodo para tratamento terapÊutico e/ou profilÁtico de glaucoma
US8415372B2 (en) 2007-02-27 2013-04-09 Asahi Kasei Pharma Corporation Sulfonamide compound
EP2130828A4 (en) 2007-02-28 2010-12-29 Asahi Kasei Pharma Corp sulfonamide
JP5234825B2 (ja) 2007-07-02 2013-07-10 旭化成ファーマ株式会社 スルホンアミド化合物及びその結晶
TW201235040A (en) * 2011-02-04 2012-09-01 Kowa Co Drug therapy for preventing or treating glaucoma
JP2013129605A (ja) * 2011-12-20 2013-07-04 Kowa Co 緑内障治療薬を含有する安定なフィルム製剤
JP2013129604A (ja) * 2011-12-20 2013-07-04 Kowa Co 緑内障治療薬を含有する徐放性フィルム製剤
JP2015229671A (ja) * 2014-06-06 2015-12-21 株式会社デ・ウエスタン・セラピテクス研究所 網膜色素上皮細胞保護剤
KR102432692B1 (ko) 2014-09-24 2022-08-12 교와 가부시키가이샤 각막 두께 조절제
WO2016047721A1 (ja) * 2014-09-25 2016-03-31 興和株式会社 医薬製剤
JP6236166B2 (ja) * 2014-09-25 2017-11-22 興和株式会社 水性組成物
KR20160108121A (ko) 2015-03-06 2016-09-19 코와 가부시키가이샤 수성 조성물
TWI699207B (zh) * 2015-08-31 2020-07-21 日商興和股份有限公司 拉巴斯吉之用於製造眼壓下降增強劑之用途

Family Cites Families (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2554816A (en) * 1950-04-04 1951-05-29 American Cyanamid Co Heterocyclic sulfonamides and methods of preparation thereof
US3885047A (en) * 1972-06-16 1975-05-20 Mead Johnson & Co Ocular hypotensive process employing dextrorotatory phenethanolamines
US4483864A (en) * 1983-02-04 1984-11-20 University Of Iowa Research Foundation Non-classical topical treatment for glaucoma
JPS61227581A (ja) 1985-04-02 1986-10-09 Asahi Chem Ind Co Ltd 血管拡張剤
US4797413A (en) * 1986-05-14 1989-01-10 Merck & Co., Inc. Thieno thiopyran sulfonamide derivatives, pharmaceutical compositions and use
DE3871596T3 (de) 1987-04-03 2000-09-07 Pharmacia & Upjohn Ab, Stockholm Anwendung eines Prostaglandins in Mischung mit einem adrenergischen Blocker zur Verminderung des Augen-Innendruckes.
US5153192A (en) 1990-04-09 1992-10-06 Alcon Laboratories, Inc. Thiophene sulfonamides useful as carbonic anhydrase inhibitors
AU9646198A (en) * 1997-10-22 1999-05-10 Nippon Shinyaku Co. Ltd. Isoquinoline derivative and drug
JP4212149B2 (ja) 1998-06-11 2009-01-21 株式会社デ・ウエスタン・セラピテクス研究所 医薬
CN1195547C (zh) * 1998-08-17 2005-04-06 千寿制药株式会社 青光眼预防、治疗药
US7217722B2 (en) 2000-02-01 2007-05-15 Kirin Beer Kabushiki Kaisha Nitrogen-containing compounds having kinase inhibitory activity and drugs containing the same
WO2001068607A1 (fr) 2000-03-16 2001-09-20 Mitsubishi Pharma Corporation Composes d'amide et utilisation
US20030018079A1 (en) 2000-11-13 2003-01-23 Richardson Helene Treatment
US7442686B2 (en) * 2001-04-12 2008-10-28 Bioaxone Therapeutique Inc. Treatment of macular degeneration with ADP-ribosyl transferase fusion protein therapeutic compositions
MXPA04005674A (es) * 2001-12-12 2004-10-15 Pharmacia Corp Metodo para tratar trastornos oftalmicos con antagonistas epoxi-esteroidales del receptor de aldosterona.
CA2472619A1 (en) 2002-01-10 2003-07-24 Bayer Corporation Fused pyrimidine derivates as rho-kinase inhibitors
DE60318177T2 (de) 2002-01-23 2008-10-09 Bayer Pharmaceuticals Corp., West Haven Rho-kinase inhibitoren
CA2488752A1 (en) * 2002-06-17 2003-12-24 Merck & Co., Inc. Novel maxi-k channel blockers, methods of use and process for making the same
JP4482726B2 (ja) 2002-08-29 2010-06-16 参天製薬株式会社 Ｒｈｏキナーゼ阻害剤とプロスタグランジン類からなる緑内障治療剤
US20050245509A1 (en) 2002-08-29 2005-11-03 Santen Pharmacecutical Co., Ltd. Remedy for glaucoma comprising rho kinase inhibitor and prostaglandins
CA2400996A1 (en) 2002-09-03 2004-03-03 Lisa Mckerracher 1,4-substituted cyclohexane derivatives
EP1562935B1 (de) 2002-10-28 2006-09-06 Bayer HealthCare AG Heteroaryloxy-substituierte phenylaminopyrimidine als rho-kinaseinhibitoren
EP1568382B1 (en) 2002-11-18 2013-11-06 Santen Pharmaceutical Co., Ltd. REMEDY FOR GLAUCOMA COMPRISING Rho KINASE INHIBITOR AND beta-BLOCKER
JP2004250410A (ja) 2003-02-21 2004-09-09 Mitsubishi Pharma Corp 腎臓における虚血−再灌流障害の治療剤
WO2004084813A2 (en) 2003-03-21 2004-10-07 Smithkline Beecham Corporation Chemical compounds
ES2387780T3 (es) 2003-10-06 2012-10-01 Glaxosmithkline Llc Preparación de azabencimidazoles 1,6-disustituidos como inhibidores de quinasas
JP2007507549A (ja) 2003-10-06 2007-03-29 グラクソ　グループ　リミテッド キナーゼ阻害剤としての１，６，７−三置換アザベンゾイミダゾールの調製
US20070123561A1 (en) 2003-10-06 2007-05-31 Dennis Lee Preparation of 1,7-disubstituted azabensimidazoles as kinase inhibitors
JP2007015928A (ja) 2003-10-15 2007-01-25 Ube Ind Ltd 新規オレフィン誘導体
KR101163800B1 (ko) 2003-10-15 2012-07-09 산텐 세이야꾸 가부시키가이샤 신규 인다졸 유도체
JP2007008816A (ja) 2003-10-15 2007-01-18 Ube Ind Ltd 新規イソキノリン誘導体
WO2005099691A1 (en) * 2004-03-31 2005-10-27 Pharmacia & Upjohn Company Llc Composition for treating elevated intraocular pressure
WO2006044232A1 (en) * 2004-10-13 2006-04-27 Merck & Co., Inc. Ophthalmic compositions for treating ocular hypertension
US20060142270A1 (en) * 2004-12-23 2006-06-29 Kowa Co., Ltd. Preventing or treating agent for glaucoma

Also Published As

Publication number Publication date
EP1905452A4 (en) 2012-02-15
WO2007007737A1 (ja) 2007-01-18
JP4972552B2 (ja) 2012-07-11
CN101198355A (zh) 2008-06-11
US8193193B2 (en) 2012-06-05
KR20080027827A (ko) 2008-03-28
KR101333990B1 (ko) 2013-11-27
US20090118299A1 (en) 2009-05-07
CN101198355B (zh) 2010-11-10
EP1905452A1 (en) 2008-04-02
EP1905452B1 (en) 2013-06-19
HRP20130876T1 (hr) 2013-10-25
ES2416334T3 (es) 2013-07-31
PT1905452E (pt) 2013-07-16
PL1905452T3 (pl) 2013-11-29
JPWO2007007737A1 (ja) 2009-01-29

Similar Documents

Publication Publication Date Title
DK1905452T3 (da) Middel til forebyggelse eller behandling af glaukom
DK1893586T3 (da) Fremgangsmåde til fremstilling af 1-alkyl-3-phenyluraciler
DK1852430T3 (da) Fremgangsmåde til fremstilling af proanthocyanidinoligomer
DK1846354T3 (da) Substituterede cyclopentaner eller cyclopentanoner til behandling af okular hypertensive tilstande
DK1948176T3 (da) Diarylurinstoffer til behandling af pulmonær hypertension
ITMO20050327A1 (it) Mola perfezionata
DK1856024T4 (da) Fremgangsmåde til fremstilling af substituerede biphenyler
DE502006007466D1 (de) Laser-Mikrodissektionsgerät
DK1881830T3 (da) 4-phenyl-5-oxo-1,4,5,6,7,8-hexahydroquinolin-derivater til behandling af infertilitet
DK1879580T3 (da) 4-phenyl-5-oxo-1,4,5,6,7,8-hexahydroquinolinderivater som lægemidler til behandling af infertilitet
NO20053226D0 (no) Fremgangsmate for elektrokinetisk migrasjon.
DK1879581T3 (da) 4-phenyl-5-oxo-1,4,5,6,7,8-hexahydroquinolin-derivater som lægemidler til behandling af infertilitet
DK1933861T3 (da) Fremgangsmåde til behandling eller forebyggelse af multiorgansvigt
DK2366393T3 (da) Roflumilast til behandlingen af pulmonal hypertension
ES1059722Y (es) Cuerda para elementos de proteccion individual.
NL1036308A1 (nl) Lithographic method.
DK1912961T3 (da) Fremgangsmåde til fremstilling af bepromolin
NO20082650L (no) Benzenderivat eller salt derav
DK1931618T3 (da) Fremgangsmåde til fremstilling af aniliner
FR2891181B1 (fr) Dispositf pour la fente de buches
DK1992352T3 (da) Middel til anvendelse i forbyggelsen af aterosklerosis
ITPN20050088A1 (it) Cabina attrezzata per doccia.
FI20080436A (fi) Terä
FR2903669B3 (fr) 02isse demontable.
ITBO20050074A1 (it) Componente per strutture portanti